Shandong Boan Biotechnology Co (HKSE:06955) Total Inventories : HK$180.8 Mil (As of Dec. 2023)

View and export this data going back to 2022. Start your Free Trial

What is Shandong Boan Biotechnology Co Total Inventories?

Shandong Boan Biotechnology Co's total inventories for the quarter that ended in Dec. 2023 was HK$180.8 Mil. Shandong Boan Biotechnology Co's average total inventories from the quarter that ended in Jun. 2023 to the quarter that ended in Dec. 2023 was HK$178.1 Mil.

In Ben Graham's calculation of Net-Net Working Capital, inventory is only considered worth half of its book value. Shandong Boan Biotechnology Co's Net-Net Working Capital per share for the quarter that ended in Dec. 2023 was HK$-1.20.

Days Inventory indicates the number of days of goods in sales that a company has in the inventory. Shandong Boan Biotechnology Co's Days Inventory for the six months ended in Dec. 2023 was 279.92.

Inventory Turnover measures how fast the company turns over its inventory within a year. Shandong Boan Biotechnology Co's Inventory Turnover for the quarter that ended in Dec. 2023 was 0.65.

Inventory-to-Revenue determines the ability of a company to manage their inventory levels. It measures the percentage of Inventories the company currently has on hand to support the current amount of Revenue. Shandong Boan Biotechnology Co's Inventory-to-Revenue for the quarter that ended in Dec. 2023 was 0.46.

Shandong Boan Biotechnology Co Total Inventories Historical Data

The historical data trend for Shandong Boan Biotechnology Co's Total Inventories can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Shandong Boan Biotechnology Co Total Inventories Chart

Shandong Boan Biotechnology Co Annual Data

Trend

Dec20

Dec21

Dec22

Dec23

Total Inventories

23.32

121.03

160.27

180.79

Shandong Boan Biotechnology Co Semi-Annual Data
	Dec20	Jun21	Dec21	Jun22	Dec22	Jun23	Dec23
Total Inventories	Get a 7-Day Free Trial			121.03	165.14	160.27	175.36	180.79

Shandong Boan Biotechnology Co Total Inventories Calculation

Total Inventories includes the raw materials, work-in-process goods and completely finished goods of a company. It is a portion of a company's current assets.

Shandong Boan Biotechnology Co (HKSE:06955) Total Inventories Explanation

Inventory control is an important part of business operation. If a company does not have enough inventory, it may not be able to meet customers' required delivery time. If it has too much inventory, the cost of holding the inventory can be high.

1. In Ben Graham's calculation of Net-Net Working Capital (NNWC), inventory is only considered worth half of its book value.

Shandong Boan Biotechnology Co's Net-Net Working Capital Per Share for the quarter that ended in Dec. 2023 is

	Net-Net Working Capital Per Share (Q: Dec. 2023 )
=	(Cash And Cash Equivalents	+	0.75 * Accounts Receivable	+	0.5 * Total Inventories	-	Total Liabilities
-	Preferred Stock	-	Minority Interest)	/	Shares Outstanding (EOP)
=	(220.779	+	0.75 * 233.193	+	0.5 * 180.792	-	1097.627
-	0	-	0)	/	509.278
=	-1.20

2. Days Inventory indicates the number of days of goods in sales that a company has in the inventory.

Shandong Boan Biotechnology Co's Days Inventory for the six months ended in Dec. 2023 is calculated as:

Days Inventory	=	Average Total Inventories (Q: Dec. 2023 )	/	Cost of Goods Sold (Q: Dec. 2023 )	*	Days in Period
	=	178.078	/	116.1	*	365 / 2
	=	279.92

3. Inventory Turnover measures how fast the company turns over its inventory within a year.

Shandong Boan Biotechnology Co's Inventory Turnover for the quarter that ended in Dec. 2023 is calculated as

Inventory Turnover	=	Cost of Goods Sold (Q: Dec. 2023 )	/	Average Total Inventories (Q: Dec. 2023 )
	=	116.1	/	178.078
	=	0.65

4. Inventory-to-Revenue determines the ability of a company to manage their inventory levels. It measures the percentage of Inventories the company currently has on hand to support the current amount of Revenue.

Shandong Boan Biotechnology Co's Inventory to Revenue for the quarter that ended in Dec. 2023 is calculated as

Inventory-to-Revenue	=	Average Total Inventories (Q: Dec. 2023 )	/	Revenue (Q: Dec. 2023 )
	=	178.078	/	390.366
	=	0.46

Be Aware

Manufacturers with durable competitive advantages have the advantage that the products they sell do not change, and therefore will never become obsolete. Buffett likes this advantage.

When identifying manufacturers with durable competitive advantage, look for inventory and net earnings that rise correspondingly. This indicates that the company is finding profitable ways to increase sales which called for an increase in inventory.

Manufacturers with inventories that spike up and down are indicative of competitive industries subject to boom and bust.

Shandong Boan Biotechnology Co Total Inventories Related Terms

Thank you for viewing the detailed overview of Shandong Boan Biotechnology Co's Total Inventories provided by GuruFocus.com. Please click on the following links to see related term pages.

Shandong Boan Biotechnology Co (HKSE:06955) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Shandong Boan Biotechnology Co Ltd (HKSE:06955) » Definitions » Total Inventories

Comparable Companies

Traded in Other Exchanges

UJ9:Germany

Address

No. 39 Keji Avenue, High-Tech Industrial Development Zone, Shandong Province, Yantai, CHN

Website

https://www.boan-bio.com

Shandong Boan Biotechnology Co Ltd is a fully integrated biopharmaceutical company. The company is engaged in the development, manufacture, and commercialization of high-quality biologics in China and around the world. It focuses on areas such as oncology, metabolism, autoimmunity, and ophthalmology. Geographically company's revenue is generated from customers located in Mainland China.

Executives

Asiapharm Investments Ltd.
Ginkgo (ptc) Limited
Liu Dianbo
Luye Life Sciences Group Ltd
Luye Pharma Holdings Ltd.
Luye Pharma Hong Kong Limited
Luye Pharmaceutical International Co., Ltd.
Luye Pharmaceutical Investment Co., Ltd.
Nelumbo Investments Limited
Shorea Lbg
Luye Pharma Group Ltd.
Shan Dong Lv Ye Zhi Yao You Xian Gong Si
Yan Tai Lv Ye Yi Yao Kong Gu Ji Tuan You Xian Gong Si
Li Li	2201 Interest of corporation controlled by you

Shandong Boan Biotechnology Co (HKSE:06955) Headlines

No Headlines